Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/27/2022 | Press release | Distributed by Public on 01/27/2022 12:38
Please select the service you want to use:
Smartlinks | Tekla Healthcare Opportunities Fund | Tekla Capital Management LLC | News | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Financial Services | Investment Funds | Investment Services | Public Companies | Closed-End Funds | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | NYSE National | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact